Cell Therapeutics, Inc. (CTIC) Misses Q4 EPS by 4c

April 27, 2011 7:23 AM
Cell Therapeutics, Inc. (NASDAQ: CTIC) reported Q4 EPS of ($0.06), $0.04 worse than the analyst estimate of ($0.02).

Categories

Earnings